chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my Pfizer booster for COVID-19 on 9/24/2021. On 7/25/2022, I didn't feel well, because I had a headache and cough. I thought I was coming down with a cold, since that was what it felt like. The symptoms continued on 7/26/2022. On the night of 7/26/2022, I woke up with chills, sweats, and a severe headache. On 7/27/2022, I had a fever of 101, along with a worsening headache. I went to the hospital and underwent a rapid test and got a positive response. I came home and rested afterwards. I was prescribed Paxlovid and began taking it the night of 7/27/2022. The headaches continued for between 7-10 days. I also had dizziness and lightheadedness; I passed out on 7/31/2022. I passed out again another day, but I don't remember it as well as I do the first time. It was maybe about 2 weeks before I began to feel better. On 8/10/2022, I went to the doctor and underwent another rapid test, and I got another positive result. Since my condition had not improved, the doctor decided to do some bloodwork, and he discovered that I was anemic. Since then, I have received 4 iron infusions; at the time of this writing, I am due to get 2 more infusions. My doctor told me that it would take several months for me to recover fully from my symptoms. I'm normally a very active person, but at this point, I can't make plans in advance, as I don't know if I will have the energy needed to follow through.
PT STATED SHE EXPERIENCE FACIAL SWELLING BUT DID NOT AFFECT BREATHING
She said she was getting second and it was discovered todays shot was her third dose.  I spoke with her dr same day and explained what had happened.   1st   12/5/2019 2nd   08-/27/2021 3rd    12/3-/2021
Livedo Reticularis (lattice hemorrhage): Inner left leg from groin to foot. Inner right leg groin to knee. Pain in both legs and left arm, which also remains swollen and painful 24 days later. Additional swelling top - both feet.  NOTE: Patient has IDENTICAL twin (verified by DNA) who had the Moderna vaccine and developed Livedo Reticularis after 2nd shot   I have photos I can send.
c/o rash, pruritus & urticaria in PM of same day vax recvd-scattered on arms & chest, more concentarted on lt arm near where vax given;  Pt states had similar event p/vax given 5MAR91;
Pt vaccinated with MMR/HIB 10 days post immunization developed temp 103- trunk rash after fever broke. Father is MD - looked like mass of small lesion.
Pt. called stating arm sore, swollen, a little warm and hard, pain from middle of upper arm. Shoulder to middle of upper arm.
I GAVE A KINRIX VACCINE WHICH IS FOR CHILDREN 4 YEARS AND OLDER TO A 6 MONTH OLD BABY.
Nerve pain to Lt. upper arm (elbow to shoulder) and continuous pain. Could not raise/lift arm. Pain was like having shingles, as I had shingles 4/15 in back.
Pentacel was given, however it was not mixed only the DTAP/Ipol portion was provided, Act-Hib portion was not given/No AE; Initial information received on 18-Nov-2019 regarding an unsolicited valid non-serious case received from an other health care professional.  This case involves an eight weeks old female patient who was given first dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5)/HIB(PRP/T) VACCINE [PENTACEL], lot UJ013AA, dose: 0.5 ml and expiry date: 10-OCT-2020  via intramuscular route in the left thigh on 08-Nov-2019, however, it was not mixed (only DTAP / Ipol portion was provided to the patient, the Act-HIB portion was not administered).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13), HEPATITIS B VACCINE (HEPATITIS B VACCINE) and ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) oral.  It was a case of actual medication error due to inappropriate reconstitution technique (only DTAP/Ipol portion of Pentacel was provided to the patient, the ActHIB portion was not provided).  No Adverse events were reported at the time of reporting.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
NECK TIGHT/SORE; HEADACHE; FEVER; ITCHY; SHAKING ALL OVER; CHILLS; WEAKNESS; MUSCLE ACHE; This spontaneous report received from a patient. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 14:30 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced muscle ache. Laboratory data included: Body temperature (NR: not provided) 102 F. On 08-APR-2021 19:00, the subject experienced itchy. On 08-APR-2021 19:00, the subject experienced shaking all over. On 08-APR-2021 19:00, the subject experienced chills. On 08-APR-2021 19:00, the subject experienced weakness. On 08-APR-2021 20:30, the subject experienced fever. On 09-APR-2021, the subject experienced neck tight/sore. On 09-APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from itchy, and shaking all over on 09-APR-2021, was recovering from weakness, chills, and fever, and had not recovered from muscle ache, headache, and neck tight/sore. This report was non-serious.
From the time i received my covid 19 vaccines and boosters; my wbc has been dropped from normal range to abnormal. On 12/12/2018 my WBC was 4.3. On 10/26/2022 I get another labs work done and my wbc dropped to 3.2. My concerns are not only based on just my reading but I also have other 3 people that I know who have experienced the same issue to the point where one of them had to be on meds to raise his WBC up. For your information, all of us are of the same race.
Got her eye bulging; Woke up with bells palsy in lips, nose, eye on the left side; Headache; A spontaneous report was received from a consumer concerning a 73 year old female patient, who experienced eye bulging (exophthalmos), bells palsy in lips, nose, eye on the left side (facial paralysis), and headache.  The patient's medical history was not provided by the reporter. Concomitant medications were also not reported.  On 16 Feb 2021 at 13:30, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 023M20A) for prophylaxis of COVID-19 infection.   On 16 Feb 2021 at 16:00, after receiving mRNA-1273, the patient experienced eye bulging and a headache (intermittent). The headache lasted 3 days until she took a Tylenol.  The patient reported that she woke up with bells palsy in lips, nose, eye on the left side.  The treatment details for the event of headache included Tylenol (paracetamol).   Action taken with mRNA-1273 in response to the events was unknown.   The outcome for  the events of eye bulging (exophthalmos) and  bells palsy in lips, nose, eye on the left side (facial paralysis) was considered as unknown. The event of headache recovered on 18 Feb 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This case was reported by a consumer via call center representative and described the occurrence of itchy upper limbs in a 76-year-old male patient who received SHINGRIX for prophylaxis. On 16th June 2018, the patient received the 1st dose of SHINGRIX. On 29th June 2018, 13 days after receiving SHINGRIX, the patient experienced itchy upper limbs and rash. The patient was treated with Corticosteroids Nos and dermatologicals (Cream (Nos)). On an unknown date, the outcome of the itchy upper limbs and rash were recovered/resolved. It was unknown if the reporter considered the itchy upper limbs and rash to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX in unknown deltoid. Two weeks after the patient received SHINGRIX vaccination, he developed a reaction on his upper right arm, on the skin between his elbow and shoulder that was itching and felt like mosquito bites. On 3rd July 2018, the patient was prescribed with a cream but it did not relieve the condition. On 6th July 2018, the patient took a corticosteroid that did resolve the issue.
Pt pale, complains of being flushed, dizzy, wretching and nausea.
1 week after receiving 2nd dose of Moderna Covid 19 vaccine started having increase blood pressures and then pain left temporal head.  Reports history of temporal arteritis in past and this was flared due to injection, Mild blurred vision left eye when pain flared. improving after 2-3 weeks.
Td at school. 7PM headache/dizzy. 9PM temp 102, chills. 2 500mg Tylenol. 1045PM temp 103, headache, legs ache. 1200AM Temp 102 and headache. 230AM 2 500mg Tylenol, headache, leg aches vomited. 6AM temp 100.5, headache leg aches. 7AM Temp 101.5 2 500mg Tylenol. Discharge summary states serum sickness, weakness. msv
numb arm; prickly feeling; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient (neighbour). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number, expiration date not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The reporter stated that neighbour had prickly feeling and a numb arm after the first shot (on an unspecified date). The outcome of the events numb arm and prickly feeling was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
inadvertently received an adult dose of Havrix for their second dose of the Havrix series; adult dose of Havrix for their second dose of the Havrix series; This non-serious case was reported by a nurse via call center representative and described the occurrence of accidental overdose in a adolescent female patient who received HAV (Havrix adult) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Havrix adult. On an unknown date, an unknown time after receiving Havrix adult, the patient experienced accidental overdose (Verbatim: inadvertently received an adult dose of Havrix for their second dose of the Havrix series) and inappropriate age at vaccine administration (Verbatim: adult dose of Havrix for their second dose of the Havrix series). The outcome of the accidental overdose and inappropriate age at vaccine administration were unknown.   Additional Information: GSK Receipt Date: 31-JUL-2023 The reporter reported the patient inadvertently received an adult dose of Havrix of the Havrix series, which led to accidental overdose and inappropriate age at vaccine administration. The reporter consented to follow up.
The urgent care facility diagnosed it as a mild effusion of the right elbow bursa.  Occurred within two hours after the injection on April 3.  Injection was on the right arm.  Prior to this, I had no bursa issues on any joints, leading me to believe that either it is an odd coincidence or it is somewhat vaccine or shot location related..  I have full range of motion of my elbow; there is no pain, except for pushing on the swelling.   It is not red or irritated.
At day 8, I awoke to a new lump, hot skin and red rash at injection site location.
Face started swelling  and full body hives. Face is still swollen next morning, hives have gone away though.
Chills, Low grade fever, lack of energy, dull headache, and loss of armpit hair under left arm, not all, but noticable.
Itchy red rashes appeared initially on the scalp, upper back, neck, and chest. Rashes then spread to low back, arms, groin, and thighs by the following day, 24 hours after administration of the vaccine. Currently raised welts consistent with hives are visible on 60% of the body.
Site: Pain at Injection Site-Severe, Additional Details: Pt. had pain at injection site. Pain radiated to shoulder/arm/neck. Pain not relieved by cyclobenzaprine. Pt. referred to ER for further check up as per pt's daughter.
Tinnitus / is still present / hearing high pitch sound; Did not let him fall asleep / using sleeping aid; This case was reported by a consumer via call center representative and described the occurrence of tinnitus in a male patient who received Herpes zoster (Shingrix) (batch number 5DH34, expiry date 10th December 2021) for prophylaxis.   Previously administered products included SHINGRIX with an associated reaction of no adverse event (1st dose received in 9th March 2021,lot number 73E59, Expiry date 19th November 2021,No adverse event reported by the reporter for the 1st dose). Concomitant products included Herpes zoster (Shingrix).   On 22nd June 2021 14:00, the patient received the 2nd dose of Shingrix (intramuscular). On 22nd June 2021, less than a day after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced sleeplessness. On 22nd June 2021 18:30, the patient experienced tinnitus. The patient was treated with prednisone and lorazepam. On an unknown date, the outcome of the tinnitus was not recovered/not resolved and the outcome of the sleeplessness was recovering/resolving.   It was unknown if the reporter considered the tinnitus and sleeplessness to be related to Shingrix.  Additional case details were provided as follows: The case was reporter by the patient.  The age at vaccination was not reported. The patient received the 2nd dose of Shingrix vaccine around 2 pm and started experiencing tinnitus same day around 6:30 pm.  The patient elaborated tinnitus as hearing high pitch sound, which did not let him fall asleep.  The patient was using sleeping aid (lorazepam or Z-Quil) to help him go to sleep, also used noise maker (fan) so that it cancels out the high pitch sound for him to fall asleep.  Around 26th July 2021, the patient had been able to go to sleep with out sleeping aid or fan/external sound, however, tinnitus was still present. Health care professional (HCP) prescribed prednisone for 9 days, but that did not help.  The patient was also referred to see EENT (eyes/ears/nose/throat) doctor and was told that tinnitus should go away. The reporter consented to follow up. The reporter gave a consent to follow-up with HCP, however, he did not have fax number or email address
rash on palms of hands, armpits, bottom of feet and buttocks.; This is a spontaneous report from a contactable other healthcare professional. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Aug2021 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included allergic to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any vaccines within four weeks prior to vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Aug2021 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. On 31Aug2021, the patient experienced a rash on palms of hands, armpits, bottom of feet and buttocks in the morning after vaccination. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash on palms of hands, armpits, bottom of feet and buttocks was not resolved at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Jul 02, 2008-Tetanus shot-adverse reaction-diarrhea, vomiting, achy muscles. After two months my shoulder and arms/hands ache with pain. I encountered headache and still the muscle are hurting. (11.05.08).
This is a spontaneous report obtained from a contactable pharmacist who reported for her daughter. A 1-year-old female patient received the fourth dose of PREVNAR 13 on an unknown date, at single dose, for immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, the pharmacist was pretty sure the baby had pneumonia (pneumonia was not yet diagnosed). Clinical outcome was unknown at time of this report. The information on the lot number has been requested. Sender's Comments: Based on the information currently available, a lack of efficacy (pneumonia occurred after the vaccination schedule with pneumococcal 13-valent conjugate vaccine) in this patient cannot be completely excluded.
Administration of ROTATEQ after temperature excursion; This spontaneous report has been received from an unspecified reporter(non healthecare professional) concerning a patient of unknown age and gender. The patient's concurrent conditions, historical drugs, medical history and concomitant therapies were not reported.        On 14-JAN-2021, the patient was vaccinated with an improperly stored rotavirus vaccine, live, oral, pentavalent(ROTATEQ) 2 ml,  Lot # 1742457, expiration date reported as 16-FEB-2022 but upon internal validation established as 06-JAN-2022 for prophylaxis (dosage regimen was not reported). The storage temperature was reported to had been at 1.3 °C for 19 minutes.           There was digital data logger involved, no previous temperature excursion was reported and no other information was available
Dose administered too soon (16 days apart) Narrative: Second dose in COVID-19 Vaccination series administered too soon. Patient did not have reaction as a result. Per CDC guidance, doses inadvertently administered earlier than the grace period should not be repeated.
PNEUMONIA VACCINE ADMINISTERED DURING ROUTINE YEARLY PHYSICAL. PAIN THAT GOT WORSE OVER 24 HOURS/ ITCH, IMMEDIATELY/ SWELLING, 3 CM CIRCUMFERENCE OF ARM/ REDNESS FROM 1" BELOW INJECTION SITE ON UPPER LEFT ARM TO 3" BELOW ELBOW.
Pt recvd vax & 10 to 14 days later devel herpes zoster; pt was treated w/Zovirax 4 times daily for 5 days & sx abated;
baby, , given Havrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old female patient who received HAV (Havrix pediatric) (batch number 95EJ7, expiry date 6th February 2023) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 13th September 2022, the patient received the 1st dose of Havrix pediatric (intramuscular) .5 ml and Havrix Pre-Filled Syringe Device. On 13th September 2022, unknown after receiving Havrix pediatric and Havrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 13-Sep-2022 Reporter's comment: The caller was the Healthcare professional to report an adverse event. The caller reported that a baby was given the dose of Havrix. There was inappropriate schedule of vaccine. The call was transferred to Medical information for further assistance. The consent to follow up was granted. Additional Supportive information: 2 month old patient was given the dose of Havrix, which led to inappropriate age at vaccine administration.
Information has been received from a physician assistant concerning a 15 or 16 year old female patient who on unknown dates was vaccinated with a first and second dose of GARDASIL, lot number not specified. Approximately 2 weeks after the dose was given the patient experienced "panic attack", where she felt pain in her chest and rapid breathing, it happened after both doses of GARDASIL. The assistant stated that the Dr. advised not to get the 3rd dose of GARDASIL. Additional information has been requested.
had allergic reaction to it and almost wound up in ER; Initial information regarding an unsolicited valid non-serious social media case was received from a non-healthcare professional (consumer)  on 10-Dec-2020.  This case involves adult patient who had allergic reaction to it and almost wound up in ER (Hypersensitivity), while patient received vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), concomitant(s) and family history were not provided.  On an unknown date, the patient received a dose, of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route.  On unknown date, (unknown latency) the patient had allergic reaction to it and almost wound up in er (hypersensitivity) (unknown latency) following the administration of INFLUENZA VACCINE.  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  The event outcome was reported as unknown.  There will be no information available on the batch number for this case.
I had Eye allergies issues with gritty feeling in the eyes, swelling, burning sensation,  and watery eyes.  Also had sour throat and cold symptoms after the vaccine with headache and drowsiness
crushing pain in body ,especially in legs; very tired; completely wiped out; scary sick; headache; body ache; sore throat; nausea; wheezing; coughing; extremely ill; This spontaneous case was reported by a non-health professional (subsequently medically confirmed) and describes the occurrence of HEADACHE (headache), PAIN (body ache), OROPHARYNGEAL PAIN (sore throat), NAUSEA (nausea) and WHEEZING (wheezing) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Surgery (she had 2 back surgeries). Concomitant products included OXYCODONE, MARIJUANA, CODEINE PHOSPHATE, METHOCARBAMOL, PARACETAMOL (MUSCLE & BACK PAIN RELIEF [CODEINE PHOSPHATE;METHOCARBAMOL;PARACETAMOL]), OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) and LEVOTHYROXINE.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced HEADACHE (headache), PAIN (body ache), OROPHARYNGEAL PAIN (sore throat), NAUSEA (nausea), WHEEZING (wheezing), COUGH (coughing), ILLNESS (extremely ill), ILLNESS (scary sick) and FATIGUE (completely wiped out). On an unknown date, the patient experienced PAIN IN EXTREMITY (crushing pain in body ,especially in legs) and FATIGUE (very tired). At the time of the report, HEADACHE (headache), PAIN (body ache), OROPHARYNGEAL PAIN (sore throat), NAUSEA (nausea), WHEEZING (wheezing), COUGH (coughing), ILLNESS (extremely ill), PAIN IN EXTREMITY (crushing pain in body ,especially in legs), ILLNESS (scary sick), FATIGUE (very tired) and FATIGUE (completely wiped out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.